Overview

Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)

Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, phase II, open-label trial to evaluate the efficacy of pemetrexed + carboplatin combined with thoracic radiotherapy in patients with Limited Stage of small cell lung cancer
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Carboplatin
Pemetrexed